Clinical Research in Transfusion Medicine

(JIF 2022)

-Fernandez J, Delgadillo J, Vives J, Rodriguez L, Mendoza A, Azqueta C, Garcia A, Valdivia E, Martorell L, Rubio N, Linares M, Alonso S, Ancochea A, Garcfa E, García N, Medina L, Querol S. A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience. CYTOTHERAPY. 2023; 25(1)DOI:10.1016/j.jcyt.2022.07.011. PMID:36041984. IF:4,500 (Q2/3D). Document type: Article.

-Martínez IR, Avendaño C, Da CV, Llobet AB, Erce J, Fraile M, Domínguez LG, Andrés IV, Velasco JA, Rodríguez VPG, Contreras E, Uranga SU, Herraiz A, Jimenez T, Pérez A, Rodríguez J, Pérez M, Ramos A, Velasco A, Cabrera JLB, Duarte RF. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. VOX SANGUINIS. 2023; 119(1)DOI:10.1111/vox.13561. PMID:37986640. IF:2,700 (Q3/7D). Document type: Article.

-Pascual C, Salmeron PP, Ruiz FT, Ferreiras DV, Hernandez SJ, Argente RS, Galan CD, Comos JD. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments – an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES). Emergencias. 2023; 35(1)PMID:36756916. IF:5,500 (Q1/2D). Document type: Review.

-Regalado I, Garcia M, Medina L, Fernandez J, Esquirol A, Garcia I, Martino R, Briones J, Sierra J, Novelli S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8)DOI:10.1111/vox.13486. PMID:37356813. IF:2,700 (Q3/7D). Document type: Article.

(JIF 2022)

• Fernandez J, Cid J, Azqueta C, Valdivia E, Martorell L, Codinach M, Marsal J, Mussetti A, Esquirol A, Trabazo M, Benitez MI, Ferra C, Fox ML, Linares M, Alonso E, Garcia E, Garcia N, Medina L, Castillo N, Vall F, Garcia A, Pinacho A, Talarn C, Arroba JG, Coll R, Santos M, Valero O, Carreras E, Lozano M, Querol S. Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(8). DOI:10.1038/s41409-022-01722-6. PMID:35614316. IF:4,8 (Q1/2D). Document type: Letter.
• Fernandez J, Horton R, Cid J, Azqueta C, Garcia A, Valdivia E, Martorell L, Rubio N, Codinach M, Aran G, Marsal J, Mussetti A, Martino R, Diaz C, Ferra C, Valcarcel D, Linares M, Ancochea A, Garcia E, Garcia N, Medina L, Carreras E, Villa J, Lozano M, Gibson D, Querol S. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry. BONE MARROW TRANSPLANTATION. 2022; 57(10). DOI:10.1038/s41409-022-01750-2. PMID:35804055. IF:4,8 (Q1/2D). Document type: Article.
• Medina L, et al. (2022) Capítulo 2.6: Obtención de PH de sangre periférica. In: Carreras E, Rovira M, Válcarcel E (eds.). Manual de Trasplante Hematopoyético. Editorial Escofet. 6a edició. ISBN:9788496928008. 1ª signant. Document type: Book chapter.

• Avendano C, Ramos A, Munez E, Ruiz B, de Molina RM, Torres F, Fernandez A, Calderon J, Payares C, de Santiago AD, Romera I, Pintos I, Lora J, Mancheno M, Paciello ML, Martinez AL, Vidan J, Nunez MJ, Saez MI, Porras ML, Jarilla MC, Villares P, de Oteyza JP, Ramos A, Blanco L, Madrigal ME, Rubio M, Velasco A, Pano JR, Moreno JA, Muniz E, et al. [Bösch A]. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. JOURNAL OF CLINICAL INVESTIGATION. 2021; 131(20):e152740. DOI:10.1172/JCI152740. PMID:34473652. IF:19,456.
• Del Barrio BV, Maya S, Rodriguez JJ, Suris CC, Llobet AB, Lopez MA. Neonatal Immune Neutropenia due to Isoantibodies against the Granulocyte Receptor Fc gamma RIIIb. TRANSFUSION MEDICINE AND HEMOTHERAPY. 2021; 48(4). DOI:10.1159/000514488. PMID:34539322. IF:4,040.
• Demelo P, Farfan AI, Pedrajas JM, Llamas P, Siguenza P, Jaras MJ, Quintana M, Fernandez C, Bikdeli B, Jimenez D, Monreal M, Olivera PE, RIETE I. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2021; 19(8). DOI:10.1111/jth.15400. PMID:34018658. IF:16,036.
• Fernandez J, Azqueta C, Valdivia E, Martorell L, Medina L, Martinez N, Torrents S, Codinach M, Canals C, Elorza I, Parody R, Martino R, Trabazo M, de Heredia CD, Ferra C, Valcarcel D, Linares M, Ancochea A, Garcia E, Garcia N, Medina L, Castillo N, Carreras E, Villa J, Querol S. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?. BONE MARROW TRANSPLANTATION. 2021; 56(10). DOI:10.1038/s41409-021-01367-x. PMID:34127808. IF:5,174.
• Muniz E, Llopis J, Parra R, Roig I, Ferrer G, Grifols J, Millan A, Ene G, Ramiro L, Maglio L, Garcia N, Pinacho A, Jaramillo A, Pero A, Artaza G, Valles R, Sauleda S, Puig L, Contreras E. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfusion. 2021; 19(1). DOI:10.2450/2020.0256-20. PMID:33196417. IF:5,752.